Amid concerns it might leave the UK, the pharma giant reaffirmed its commitment to the country, keeping its headquarters, primary listing, and tax base there.
AstraZeneca was the first pharmaceutical laboratory to launch a vaccine on the market at the end of 2020, a year after the appearance of the virus.